Drug Type Small molecule drug |
Synonyms Arelix, Prilace, Ramipril/piretanide + [2] |
Target |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors), NKCC2 inhibitors(Sodium-(potassium)-chloride cotransporter 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 2000), |
Regulation- |
Molecular FormulaC23H32N2O5 |
InChIKeyHDACQVRGBOVJII-JBDAPHQKSA-N |
CAS Registry87333-19-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Essential Hypertension | - | 01 Jan 2000 |